Jones Financial Companies’s Gain Therapeutics GANX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.33M | Buy |
676,888
+249,188
| +58% | +$491K | ﹤0.01% | 899 |
|
|
2025
Q1 | $808K | Buy |
427,700
+329,450
| +335% | +$623K | ﹤0.01% | 944 |
|
|
2024
Q4 | $212K | Buy |
98,250
+44,750
| +84% | +$96.7K | ﹤0.01% | 1327 |
|
|
2024
Q3 | $106K | Buy |
53,500
+46,500
| +664% | +$92.5K | ﹤0.01% | 1376 |
|
|
2024
Q2 | $8.96K | Buy |
+7,000
| New | +$8.96K | ﹤0.01% | 1788 |
|